TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
Tao Y, Yang G, Yang H, Song D, Hu L, Xie B, Wang H, Gao L, Gao M, Xu H, Xu Z, Wu X, Zhang Y, Zhu W, Zhan F, Shi J.
Tao Y, et al. Among authors: yang g, yang h.
Oncotarget. 2017 Apr 18;8(16):26718-26731. doi: 10.18632/oncotarget.14957.
Oncotarget. 2017.
PMID: 28157697
Free PMC article.